Roflumilast cream adds a much-needed element of simplicity for psoriasis patients and their dermatologists.
Drs Mark G. Lebwohl and Joseph F. Merola discuss how patient presentation differs in patients with PsO and PsA.
Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, discuss updates in the pathogenesis of PsA and PsO.
Arcutis Biotherapeutics’ roflumilast cream showed higher efficacy compared to vehicle in two phase 3 studies.
Continued research and development are resulting in exciting new treatment options for major dermatological conditions.
At the Skin of Color Update meeting in New York City, Mona Shahriari, MD, FAAD, shares her thoughts on prescribing the recently-approved tapinarof (VTAMA) for plaque psoriasis.
Deucravacitinib offers new hope for those with moderate-to-severe plaque psoriasis.
The relationship between mental health and psoriasis was discussed at EADV Congress 2022 in Milan, Italy.
Pediatric skin conditions can cause feelings of sadness or self-consciousness and have an impact on friendships as a result of the disease.
Wilson Liao, MD, professor and vice chair of research in the Department of Dermatology at the University of California, San Francisco (UCSF) School of Medicine, and colleagues conducted a study examining the role of supplements and diets in managing psoriasis.